Development of multiplex real-time PCR for detection of clarithromycin resistance genes for the group.

Clicks: 230
ID: 276657
2023
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #21 of 38 articles by views in Journal of medical microbiology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The molecular identification and its drug-resistance profile are important to choose the correct therapy. This work developed a multiplex real-time PCR (mqPCR) for detection of clarithromycin resistance genes for the group. Isolates received by Adolfo Lutz Institute from 2010 to 2012, identified by PCR restriction enzyme analysis of a fragment of the 65 gene (PRA-65) as type 1 (=135) and 2 (=71) were used. Drug susceptibility test (DST) for CLA were performed with reading on days 3 and 14. Subespecies identification by 65 and B genes sequencing and (41) and genes for mutation detection and primer design were performed. (41) gene deletion was detected by conventional PCR. Primers and probes were designed for five detections: (41) gene full size and with deletion; (41) gene T28 and C28; gene A2058. In total, 191/206 (92.7 %) isolates were concordant by all methods and 13/206 (6.3 %) were concordant only between molecular methods. Two isolates (1.0 %) were discordant by mqPCR compared to gene sequencing. The mqPCR obtained 204/206 (99.0 %) isolates in agreement with the gold standard, with sensitivity and specificity of 98 and 100 %, respectively, considering the gold standard method and 92 and 93 % regarding DST. The mqPCR developed by us proved to be an easy-to-apply tool, minimizing time, errors and contamination.
Reference Key
pedace2023developmentjournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Journal of medical microbiology
Year 2023
DOI
10.1099/jmm.0.001670
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.